# Editas Medicine (EDIT) — Earnings

EDIT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/edit/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.28 |
| EPS estimate | −$0.30 |
| EPS surprise | +5.44% |
| Revenue surprise | +52.61% |
| Revenue | $7.5M |
| Revenue estimate | $4.9M |
| Reported | Nov 10, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1650664/000165066425000156/edit-20250930.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 10, 2025 | −$0.30 | −$0.28 | 5.44% | $4.9M | $7.5M |
| Q2 2025 | Aug 12, 2025 | −$0.39 | −$0.63 | -61.29% | $2.3M | $3.6M |
| Q1 2025 | May 12, 2025 | −$0.56 | −$0.92 | -63.12% | $641,909.00 | $4.7M |
| Q4 2024 | Mar 5, 2025 | −$0.38 | −$0.55 | -45.73% | $29.8M | $30.6M |
| Q3 2024 | Nov 4, 2024 | −$0.75 | −$0.75 | -0.40% | $3.9M | $61,000.00 |
| Q2 2024 | Aug 7, 2024 | −$0.70 | −$0.82 | -16.48% | $4.8M | $513,000.00 |
| Q1 2024 | May 8, 2024 | −$0.63 | −$0.76 | -21.48% | $11.1M | $1.1M |
| Q4 2023 | Feb 28, 2024 | −$0.59 | −$0.23 | 61.28% | $3.7M | $60.0M |
| Q3 2023 | Nov 3, 2023 | −$0.58 | −$0.55 | 4.36% | $3.7M | $5.3M |
| Q2 2023 | Aug 2, 2023 | −$0.77 | −$0.56 | 26.98% | $4.2M | $2.9M |
| Q1 2023 | May 5, 2023 | −$0.78 | −$0.71 | 9.45% | $3.3M | $9.9M |
| Q4 2022 | Feb 22, 2023 | −$0.79 | −$0.88 | -11.59% | $3.7M | $6.5M |
| Q3 2022 | Nov 2, 2022 | −$0.85 | −$0.81 | 5.03% | $4.4M | $42,000.00 |
| Q2 2022 | Aug 3, 2022 | −$0.81 | −$0.78 | 3.50% | $4.3M | $6.4M |
| Q1 2022 | May 4, 2022 | −$0.78 | −$0.74 | 5.33% | $3.9M | $6.8M |
| Q4 2021 | Feb 24, 2022 | −$0.71 | −$0.61 | 14.35% | $4.6M | $12.5M |
| Q3 2021 | Nov 8, 2021 | −$0.81 | −$0.57 | 29.88% | $4.7M | $6.2M |
| Q2 2021 | Aug 4, 2021 | −$0.82 | −$0.81 | 1.64% | $6.0M | $379,000.00 |
| Q1 2021 | May 5, 2021 | −$0.74 | −$0.86 | -15.62% | $5.8M | $6.5M |
| Q4 2020 | Feb 25, 2021 | −$0.76 | −$1.00 | -31.58% | $5.6M | $11.4M |

## Frequently Asked Questions

### When did Editas Medicine (EDIT) last report earnings?

Editas Medicine last reported on Nov 10, 2025, covering fiscal Q3 2025.

### Did EDIT beat earnings estimates?

Yes. Editas Medicine reported EPS of −$0.28 for Q3 2025 against a −$0.30 estimate — a 5.44% beat.

### How much revenue did EDIT report last quarter?

Editas Medicine reported $7.5M in revenue for Q3 2025, against a consensus estimate of $4.9M.

## Similar Stocks

- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [NTLA](https://www.lighthorse.io/tickers/ntla) — Intellia Therapeutics, Inc. - Common Stock
- [BEAM](https://www.lighthorse.io/tickers/beam) — Beam Therapeutics Inc. - Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).